Breast Cancer in Kenya: Incidence, Screening, Treatment and the Push for Earlier Diagnosis

Breast cancer has become the most commonly diagnosed cancer in Kenya and a leading cause of cancer death among women. As communicable diseases are gradually brought under greater control, non-communicable conditions such as cancer are accounting for a growing share of the national disease burden. Understanding the scale of breast cancer in Kenya, the systems established to track it, and the barriers that delay diagnosis is essential for patients, families, health workers and the diaspora communities that often help to fund treatment.

The Scale of the Problem

According to GLOBOCAN 2020 estimates, Kenya recorded approximately 6,799 new breast cancer cases in a single year, making it the most frequently diagnosed cancer in the country. Breast cancer was associated with an estimated 3,107 deaths, ranking it among the leading causes of cancer mortality nationally. Earlier GLOBOCAN figures placed the incidence rate at roughly 40.3 per 100,000 and the mortality rate at about 17.8 per 100,000, a ratio that reflects how frequently the disease is detected at an advanced and less treatable stage.

These numbers signal a public health challenge that extends across all 47 counties, affecting women in both urban and rural settings. While breast cancer predominantly affects women, a small proportion of cases occur in men, and awareness of this fact remains limited.

The National Cancer Registry

A major step toward understanding the disease was the establishment of the National Cancer Registry of Kenya, known as NaCaRe-KE, in 2021. Population-level and facility-level registries are essential for planning services, allocating resources and measuring progress. The registry’s first report, covering July 2021 to June 2022, drew on 6,778 records notified from 42 health facilities across 21 counties. It found that the three most common cancers in the country were breast cancer at 15.1 per cent of cases, cervical cancer at 13.3 per cent and oesophageal cancer at 11.8 per cent.

Registry data on breast cancer cases notified by county of usual residence between 2020 and 2023 totalled 4,824 people, with Nairobi County recording the highest number at 550, followed by Nakuru County with 398. These distributions partly reflect where diagnostic and reporting capacity is concentrated rather than true geographic differences in risk, underscoring the need to expand cancer services beyond the major urban centres. The registry is maintained by the National Cancer Institute of Kenya.

Why Diagnosis Comes Late

One of the most consistent findings in Kenyan oncology is that a large share of breast cancers are diagnosed at stages III and IV, when treatment is more complex, more expensive and less likely to be curative. Several interlocking factors contribute to late presentation. Limited public awareness means that symptoms such as a breast lump may be ignored or misattributed. Stigma and fear of a cancer diagnosis can discourage women from seeking help. Many patients first consult traditional or faith-based healers before reaching the formal health system.

Structural barriers compound these behavioural ones. Diagnostic services such as mammography, ultrasound and pathology are unevenly distributed, concentrated in larger towns and referral hospitals. The cost of investigations and treatment, and the distances patients must travel, create further delays. Studies using national survey data, including the 2022 Kenya Demographic and Health Survey implemented with the Kenya National Bureau of Statistics, have repeatedly identified low rates of clinical breast examination and screening uptake as a key weakness in early detection.

Screening and Early Detection

International guidance emphasises a tiered approach to early detection in resource-constrained settings: widespread awareness and breast self-examination, clinical breast examination by trained health workers, and targeted mammographic screening where capacity exists. In Kenya, breast awareness campaigns are most visible during October, the global breast cancer awareness month, when hospitals, civil society organisations and the media promote self-examination and prompt presentation.

Strengthening primary-level clinical breast examination is widely seen as the most scalable intervention, because it does not require expensive equipment and can be delivered close to where people live. Expanding the number of pathologists, oncologists and diagnostic machines remains a longer-term priority. Health-promotion messaging encourages women to become familiar with the normal look and feel of their breasts and to seek care promptly if they notice a lump, skin change, nipple discharge or other persistent abnormality.

Treatment and the Cost of Care

Breast cancer treatment typically combines surgery, chemotherapy, radiotherapy and, where appropriate, hormonal and targeted therapies. Kenya’s oncology capacity has grown, with services at national referral hospitals and a number of county and private facilities, but radiotherapy machines and specialist staff remain concentrated in a few centres, creating long waiting times and heavy travel burdens for patients from distant counties.

The financial cost of cancer care is a major source of household impoverishment. Health-financing reforms, including the transition toward a national health insurance framework, aim to improve coverage for cancer diagnosis and treatment, though gaps in benefit packages and reimbursement levels continue to leave many families exposed. The national cancer response is guided by strategies developed under the Ministry of Health, including successive national cancer control strategies that set out goals for prevention, early detection, treatment and palliative care.

The Diaspora Dimension

For the Kenyan diaspora, breast cancer is both a personal and a financial concern. Remittances frequently help to fund diagnostic tests, surgery and chemotherapy for relatives at home, and diaspora networks often mobilise to support patients through fundraising. Some families seek treatment abroad for complex cases, although the expansion of domestic oncology capacity is gradually changing this pattern. Diaspora professionals in medicine and public health also contribute through training partnerships, equipment donations and advocacy for stronger cancer services.

Awareness within diaspora communities matters for another reason: encouraging relatives in Kenya to take symptoms seriously and to seek timely care can shorten the critical interval between the first sign of disease and the start of treatment, which is one of the strongest determinants of survival.

Prevention and Risk Reduction

While not all breast cancers are preventable, certain measures can reduce risk or improve outcomes. Maintaining a healthy weight, remaining physically active, limiting alcohol consumption and breastfeeding where possible are associated with modestly lower risk. The single most important lever, however, is early detection, because breast cancer caught at an early, localised stage is far more treatable than disease that has spread.

Conclusion

Breast cancer represents one of the defining non-communicable disease challenges facing Kenya. The establishment of the National Cancer Registry, the growth of oncology services and the steady expansion of awareness campaigns mark real progress, yet late diagnosis, uneven access and the high cost of care continue to undermine outcomes. Closing the gap will require stronger primary-level screening, wider diagnostic and treatment capacity, better financial protection and sustained public awareness — at home and across the diaspora.

This article is intended for general information and does not constitute medical advice. Anyone concerned about breast cancer symptoms or risk should consult a qualified health professional.